ASCO 2012 LC Highlights: Dr. Mark Socinski on TAILOR Trial in EGFR wild type Advanced NSCLC (audio)
- Author
- cancerGRACE - H. Jack West, MD
- Published
- Mon 27 Aug 2012
- Episode Link
- http://cancergrace.libsyn.com/asco-2012-lc-highlights-dr-mark-socinski-on-tailor-trial-in-egfr-wild-type-advanced-nsclc-audio
Dr. Mark Socinski from University of Pittsburgh summarizes and critiques the TAILOR trial of Taxotere (docetaxel) vs. Tarceva (erlotinib) in EGFR wild type advanced NSCLC.
